mFOLFIRINOX adjuvant chemotherapy

DRUG2 trials

Sponsors

Fudan University, SONIRE Therapeutics Inc.

Conditions

Circulating Tumor DNA MethylationHigh-risk Stage II Colorectal CancerPancreatic CancerStage III Colorectal Cancer

Early Phase 1

Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)

RecruitingNCT07033689

SONIRE Therapeutics Inc.Pancreatic Cancer

Start: 2026-01-05End: 2027-03-01Target: 10Updated: 2026-04-03

Phase 3

Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cancer

RecruitingNCT05954078

Fudan UniversityCirculating Tumor DNA Methylation, High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer

Start: 2023-08-01End: 2028-06-30Target: 340Updated: 2024-05-20